TAU researchers successfully complete first 3D-bioprinting of active tumor

Researchers at Tel Aviv University have marked a scientific breakthrough in the battle against cancer by successfully completing the first 3D-bioprinting of an entire active tumor.

According to the university, the researchers created a 3D print of glioblastoma — the deadliest type of brain cancer — from human glioblastoma tissues which contain all components of the malignant tumor.

“The breakthrough will enable much faster prediction of best treatments for patients, accelerate the development of new drugs and discovery of new druggable targets,” says the university in a statement.

The 3D model of the tumor includes “a complex system of blood vessel-like tubes through which blood cells and drugs can flow, simulating a real tumor,” according to the university.